Systems and methods for assessment of tissue function based on vascular disease
Systems and methods are disclosed for assessing tissue function based on vascular disease. One method includes receiving a patient-specific anatomic model generated from patient-specific imaging of at least a portion of a patient's tissue; receiving a patient-specific vascular model generated from patient-specific imaging of at least a portion of a patient's vasculature; receiving an estimate of blood supplied to a portion of the patient-specific anatomic model; and determining a characteristic of the function of the patient's tissue using the estimate of blood supplied to the portion of the patient-specific anatomic model.
1. A computer-implemented method of assessing tissue function, the method comprising:
receiving a patient-specific vascular model generated from patient-specific imaging of at least a portion of a vasculature of a patient;
computing a blood flow through the patient-specific vascular model;
estimating a functionally significant compromise of blood flow through at least one vessel of the patient-specific vascular model;
receiving a patient-specific tissue model generated from patient-specific imaging;
dividing the patient-specific tissue model into one or more subsections;
determining a relationship between (a) the at least one vessel having a functionally significant compromise of blood flow and (b) at least one subsection of the one or more subsections of the patient-specific tissue model;
computing, for the at least one each subsection of the one or more subsections of the patient-specific tissue model, a corresponding perfusion value based on the computed blood flow;
simulating a treatment of the at least one subsection of the one or more subsections of the patient-specific tissue model by updating the patient-specific vascular model or the one or more subsections at least one subsection of the patient-specific tissue model based on the estimated functionally significant compromise of blood flow and the determined relationship;
computing an updated perfusion value of the at least one subsection of the patient-specific tissue model of the one or more subsections, using the updated patient-specific vascular model or the updated one or more subsections at least one subsection of the patient-specific tissue model; and
generating a treatment recommendation for the at least one subsection of the one or more subsections, based on the updated perfusion value of the at least one subsection.
2. The computer-implemented method of claim 1 , wherein determining the relationship includes identifying, based on the computed perfusion value, a perfusion deficit in the at least one subsection of the patient-specific tissue model; and wherein the generating the treatment recommendation is based on the identified perfusion deficit.
3. The computer-implemented method of claim 1 , further comprising:
conducting an assessment of tissue function based on the computed blood flow or the computed perfusion value.
4. The computer-implemented method of claim 3 , wherein the assessment of tissue function includes an assessment of a patient's risk relating to electrical activation, arrhythmia, tachycardia, fibrillation, ejection fraction, stroke volume, aortic pressure, fractional shortening, cardiac index, cardiac output, capacity to perform physical activity, cardiac arrest, pain, claudication, or a combination thereof.
5. The computer-implemented method of claim 3 , wherein the assessment of tissue function includes an assessment of one or more patient-specific tissue characteristic values including a measure of electrical conductance, muscle contractility, wall motion, or a combination thereof.
6. The computer-implemented method of claim 1 , further comprising:
generating a patient-specific electrophysiological and/or biomechanical model of the patient's tissue as a function of the computed blood flow; and
calculating a patient-specific tissue characteristic value using the patient-specific electrophysiological and/or biomechanical model of the patient's tissue.
7. The computer-implemented method of claim 1 , further comprising:
determining a vessel outlet of the patient-specific vascular model, wherein the computing, for the at least one subsection of the patient-specific tissue model, a corresponding perfusion value is based on the determined vessel outlet.
8. The computer-implemented method of claim 1 , wherein the treatment recommendation includes an evaluation of stent insertion, angioplasty, bypass graft, drugs, increased physical fitness, diet, smoking cessation, recannulation, embolization, valve replacement, and/or ablation therapy.
9. The computer-implemented method of claim 1 , further comprising using machine learning to associate the blood flow with one or more subsections of the patient-specific tissue model.
10. A system for assessing tissue function, the system comprising:
a data storage device storing instructions for assessing tissue function based on vascular disease; and
a processor configured to execute the instructions to perform a method including:
receiving a patient-specific vascular model generated from patient-specific imaging of at least a portion of a vasculature of a patient;
computing a blood flow through the patient-specific vascular model;
estimating a functionally significant compromise of blood flow through at least one vessel of the patient-specific vascular model;
receiving a patient-specific tissue model generated from patient-specific imaging;
dividing the patient-specific tissue model into one or more subsections;
determining a relationship between (a) the at least one vessel having a functionally significant compromise of blood flow and (b) at least one subsection of the one or more subsections of the patient-specific tissue model;
computing, for the at least one each subsection of the one or more subsections of the patient-specific tissue model, a corresponding perfusion value based on the computed blood flow;
simulating a treatment of the at least one subsection of the one or more subsections of the patient-specific tissue model by updating the patient-specific vascular model or the one or more subsections at least one subsection of the patient-specific tissue model based on the estimated functionally significant compromise of blood flow and the determined relationship;
computing an updated perfusion value of the at least one subsection of the patient-specific tissue model of the one or more subsections, using the updated patient-specific vascular model or the updated one or more subsections at least one subsection of the patient-specific tissue model; and
generating a treatment recommendation for the at least one subsection of the one or more subsections, based on the updated perfusion value of the at least one subsection.
11. The system of claim 10 , wherein determining the relationship includes identifying, based on the computed perfusion value, a perfusion deficit in the at least one subsection of the patient-specific tissue model; and wherein the generating the treatment recommendation is based on the identified perfusion deficit, determining the relationship includes identifying, based on the computed perfusion value, a perfusion deficit in the at least one subsection of the patient-specific tissue model; and
generating the treatment recommendation based on the identified perfusion deficit.
12. The system of claim 10 , wherein the system is further configured for:
conducting an assessment of tissue function based on the computed blood flow or one or more of the computed perfusion value.
13. The system of claim 12 , wherein the assessment of tissue function includes an assessment of a patient's risk relating to electrical activation, arrhythmia, tachycardia, fibrillation, ejection fraction, stroke volume, aortic pressure, fractional shortening, cardiac index, cardiac output, capacity to perform physical activity, cardiac arrest, pain, claudication, or a combination thereof.
14. The system of claim 12 , wherein the assessment of tissue function includes an assessment of one or more patient-specific tissue characteristic values including a measure of electrical conductance, muscle contractility, wall motion, or a combination thereof.
15. The system of claim 10 , wherein the system is further configured for:
generating a patient-specific electrophysiological and/or biomechanical model of the patient's tissue as a function of the computed blood flow; and
calculating a patient-specific tissue characteristic value using the patient-specific electrophysiological and/or biomechanical model of the patient's tissue.
16. The system of claim 10 , wherein the system is further configured for:
determining a vessel outlet of the patient-specific vascular model, wherein the computing, for the at least one subsection of the patient-specific tissue model, a corresponding perfusion value is based on the determined vessel outlet.
17. The system of claim 10 , wherein the treatment recommendation includes an evaluation of stent insertion, angioplasty, bypass graft, drugs, increased physical fitness, diet, smoking cessation, recannulation, embolization, valve replacement, and/or ablation therapy.
18. A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for performing a method of assessing tissue function, the method comprising:
receiving a patient-specific vascular model generated from patient-specific imaging of at least a portion of a vasculature of a patient;
computing a blood flow through the patient-specific vascular model;
estimating a functionally significant compromise of blood flow through at least one vessel of the patient-specific vascular model;
receiving a patient-specific tissue model generated from patient-specific imaging;
dividing the patient-specific tissue model into one or more subsections;
determining a relationship between (a) the at least one vessel having a functionally significant compromise of blood flow and (b) at least one subsection of the one or more subsections of the patient-specific tissue model;
computing, for the at least one each subsection of the one or more subsections of the patient-specific tissue model, a corresponding perfusion value based on the computed blood flow;
simulating a treatment of the at least one subsection of the one or more subsections of the patient-specific tissue model by updating the patient-specific vascular model or the one or more subsections at least one subsection of the patient-specific tissue model based on the estimated functionally significant compromise of blood flow and the determined relationship;
computing an updated perfusion value of the at least one subsection of the patient-specific tissue model of the one or more subsections, using the updated patient-specific vascular model or the updated one or more subsections at least one subsection of the patient-specific tissue model; and
generating a treatment recommendation for the at least one subsection of the one or more subsections, based on the updated perfusion value of the at least one subsection.
19. The non-transitory computer readable medium of claim 18 , wherein determining the relationship includes identifying, based on the computed perfusion value, a perfusion deficit in the at least one subsection of the patient-specific tissue model; and wherein the generating the treatment recommendation is based on the identified perfusion deficit.
20. The non-transitory computer readable medium of claim 18 , the method further comprising:
conducting an assessment of tissue function based on the computed blood flow or the computed perfusion value.